Skip to Content

Desflurane Pregnancy and Breastfeeding Warnings

Desflurane is also known as: Suprane

Desflurane Pregnancy Warnings

Animal studies have revealed an increased incidence of post-implantation loss, decreased weight, and maternal toxicity.

There are no controlled data in human pregnancy.

FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

FDA pregnancy category: B

Use desflurane only if clearly needed.

See references

Desflurane Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

The effects in the nursing infant are unknown.

The concentrations of desflurane in milk are probably of no clinical importance 24 hours after anesthesia. Because of rapid washout, desflurane concentrations in milk are predicted to be below those found with other volatile potent anesthetics.

See references

References for pregnancy information

  1. "Product Information. Suprane (desflurane)." Baxter Pharmaceutical Products, Inc, New Providence, NJ.

References for breastfeeding information

  1. "Product Information. Suprane (desflurane)." Baxter Pharmaceutical Products, Inc, New Providence, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide